These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 10972844

  • 1. Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity.
    Bustamante PJ, Woodruff DC, Oh J, Keister DB, Muratova O, Williamson KC.
    Parasite Immunol; 2000 Aug; 22(8):373-80. PubMed ID: 10972844
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid.
    Vincent AA, Fanning S, Caira FC, Williamson KC.
    Parasite Immunol; 1999 Nov; 21(11):573-81. PubMed ID: 10583858
    [Abstract] [Full Text] [Related]

  • 4. A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230.
    Fanning SL, Czesny B, Sedegah M, Carucci DJ, van Gemert GJ, Eling W, Williamson KC.
    Vaccine; 2003 Jul 04; 21(23):3228-35. PubMed ID: 12804852
    [Abstract] [Full Text] [Related]

  • 5. Identification of domains within Pfs230 that elicit transmission blocking antibody responses.
    Tachibana M, Miura K, Takashima E, Morita M, Nagaoka H, Zhou L, Long CA, Richter King C, Torii M, Tsuboi T, Ishino T.
    Vaccine; 2019 Mar 22; 37(13):1799-1806. PubMed ID: 30824357
    [Abstract] [Full Text] [Related]

  • 6. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
    Healer J, McGuinness D, Carter R, Riley E.
    Parasitology; 1999 Nov 22; 119 ( Pt 5)():425-33. PubMed ID: 10599074
    [Abstract] [Full Text] [Related]

  • 7. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.
    MacDonald NJ, Nguyen V, Shimp R, Reiter K, Herrera R, Burkhardt M, Muratova O, Kumar K, Aebig J, Rausch K, Lambert L, Dawson N, Sattabongkot J, Ambroggio X, Duffy PE, Wu Y, Narum DL.
    J Biol Chem; 2016 Sep 16; 291(38):19913-22. PubMed ID: 27432885
    [Abstract] [Full Text] [Related]

  • 8. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.
    Coban C, Philipp MT, Purcell JE, Keister DB, Okulate M, Martin DS, Kumar N.
    Infect Immun; 2004 Jan 16; 72(1):253-9. PubMed ID: 14688103
    [Abstract] [Full Text] [Related]

  • 9. N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.
    Tachibana M, Wu Y, Iriko H, Muratova O, MacDonald NJ, Sattabongkot J, Takeo S, Otsuki H, Torii M, Tsuboi T.
    Clin Vaccine Immunol; 2011 Aug 16; 18(8):1343-50. PubMed ID: 21715579
    [Abstract] [Full Text] [Related]

  • 10. Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate.
    Williamson KC, Fujioka H, Aikawa M, Kaslow DC.
    Mol Biochem Parasitol; 1996 Jun 16; 78(1-2):161-9. PubMed ID: 8813686
    [Abstract] [Full Text] [Related]

  • 11. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
    Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, Nikolaeva D, Diakite M, Fairhurst RM, Fay MP, Long CA, Tsuboi T.
    Infect Immun; 2013 Dec 16; 81(12):4377-82. PubMed ID: 24042109
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 13. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.
    Infect Immun; 2005 Nov 15; 73(11):7375-80. PubMed ID: 16239536
    [Abstract] [Full Text] [Related]

  • 14. Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum.
    Singh SK, Thrane S, Chourasia BK, Teelen K, Graumans W, Stoter R, van Gemert GJ, van de Vegte-Bolmer MG, Nielsen MA, Salanti A, Sander AF, Sauerwein RW, Jore MM, Theisen M.
    Front Immunol; 2019 Nov 15; 10():1256. PubMed ID: 31231386
    [Abstract] [Full Text] [Related]

  • 15. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD, Saleh S, Kovacevic S, Wang L, Black CG, Plebanski M, Coppel RL.
    Malar J; 2011 Sep 16; 10():266. PubMed ID: 21920045
    [Abstract] [Full Text] [Related]

  • 16. Pfs230: from malaria transmission-blocking vaccine candidate toward function.
    Williamson KC.
    Parasite Immunol; 2003 Jul 16; 25(7):351-9. PubMed ID: 14521577
    [No Abstract] [Full Text] [Related]

  • 17. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.
    Roeffen W, Beckers PJ, Teelen K, Lensen T, Sauerwein RW, Meuwissen JH, Eling W.
    Exp Parasitol; 1995 Feb 16; 80(1):15-26. PubMed ID: 7529717
    [Abstract] [Full Text] [Related]

  • 18. ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.
    Miura K, Deng B, Wu Y, Zhou L, Pham TP, Diouf A, Wu CK, Lee SM, Plieskatt JL, Morin MJ, Long CA.
    Vaccine; 2019 Apr 03; 37(15):2073-2078. PubMed ID: 30850239
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
    Paul NH, Vengesai A, Mduluza T, Chipeta J, Midzi N, Bansal GP, Kumar N.
    Acta Trop; 2016 Nov 03; 163():103-8. PubMed ID: 27491342
    [Abstract] [Full Text] [Related]

  • 20. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A.
    Malar J; 2007 Aug 08; 6():107. PubMed ID: 17686163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.